Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance.
Atypical antipsychotic drugs such as Olanzapine induce weight gain and metabolic changes associated with the development of type 2 diabetes. The mechanisms underlying the metabolic side-effects of these centrally acting drugs are still unknown to a large extent. We compared the effects of peripheral...
Main Authors: | Elodie M Girault, Anneke Alkemade, Ewout Foppen, Mariëtte T Ackermans, Eric Fliers, Andries Kalsbeek |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3419184?pdf=render |
Similar Items
-
Sexual dimorphism in hepatic, adipose tissue and peripheral tissue insulin sensitivity in obese humans
by: Kasper W. ter Horst, et al.
Published: (2015-11-01) -
Energy Homeostasis and Body Weight before and after Cessation of Block and Replacement Therapy in Euthyroid Patients with Graves' Disease
by: Lars P. Klieverik, et al.
Published: (2011-01-01) -
Hepatic and peripheral effects of four insulin analogues
by: Shojaee-Moradie, Fariba
Published: (1995) -
Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration
by: Zain Mohd, et al.
Published: (2012-10-01) -
Circadian control of the daily plasma glucose rhythm: an interplay of GABA and glutamate.
by: Andries Kalsbeek, et al.
Published: (2008-09-01)